Hexamer Therapeutics, Inc
Biotechnology company · Pullman, Washington, United States
Hexamer Therapeutics, Inc is a biotechnology company headquartered in Pullman, Washington, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $651,265 sold in a notice filed in 2024.
Hexamer Therapeutics at a glance
What does Hexamer Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $651,265 sold (2024).
Frequently asked questions about Hexamer Therapeutics
Where is Hexamer Therapeutics headquartered?
Hexamer Therapeutics, Inc is headquartered in Pullman, Washington, United States.
What does Hexamer Therapeutics do?
Hexamer Therapeutics, Inc is a biotechnology company.
When was Hexamer Therapeutics founded?
The earliest incorporation on record for Hexamer Therapeutics, Inc is in 2019, according to public company registers.
Similar companies
- Cancer Targeted Technology LLCPullman, Washington, United States
- Photon Biosciences LLCPullman, Washington, United States
- DL Adv-Tech, LLCPullman, Washington, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences